Alliance between the Hospital del Mar Medical Research Institute and Chemotargets to accelerate the design of new cancer therapiesStrategic Agreement • May 28th, 2022
Contract Type FiledMay 28th, 2022• The company Chemotargets –based in the Barcelona Science Park and a leader in in the global market as a provider of intelligence and drug design prediction platform– has signed a strategic agreement with the Hospital del Mar Medical Research Institute (IMIM) to discovery and development of new oncological therapies that respond to important unmet medical needs.